Type of Cancer
Genito-Urinary
Phase
Division (Location)
Study ID
NCT#
Brief Description
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial Testing Ipatasertib Plus Abiraterone Plus Prednisone/Prednisolone, Relative to Placebo Plus Abiraterone Plus Prednisone/Prednisolone in Adult Male Patients With Asymptomatic or Mildly Symptomatic, Previously Untreated, Metastatic Castrate-Resistant Prostate Cancer
To find out more about this clinical trial, or to schedule an appointment, call (201) 518-3587.